CRISPR Therapeutics AG - Common Shares (CRSP)
45.55
+0.02 (0.04%)
Crispr Therapeutics is a biopharmaceutical company that focuses on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene editing technology
The company aims to harness the potential of genetic editing to treat various conditions, including genetic disorders, cancer, and autoimmune diseases. Through a combination of innovative research and strategic collaborations, Crispr Therapeutics is dedicated to advancing its pipeline of therapies and ultimately improving patient outcomes and quality of life.
| Previous Close | 45.53 |
|---|---|
| Open | 44.67 |
| Bid | 45.41 |
| Ask | 45.74 |
| Day's Range | 44.48 - 46.07 |
| 52 Week Range | 36.52 - 79.33 |
| Volume | 475,615 |
| Market Cap | 3.60B |
| PE Ratio (TTM) | -10.47 |
| EPS (TTM) | -4.4 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 2,650,146 |
